E*Trade appoints European pharmaceutical specialist

E*Trade Securities, the institutional division of E*Trade Group, the electronic brokerage, has expanded its independent equity research team with the appointment of Michael Leacock as European pharmaceutical analyst.

Leacock joins E*Trade Securities from Credit Lyonnais, where he integrated its UK and Northern European pharmaceutical research into a pan-European product.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump